Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review

Saved in:
Bibliographic Details
Published in:Health Economics Review
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864030192735879168
collection WordPress RSS
FRELIP Feed Integration
container_title Health Economics Review
description
discipline_display Social Sciences
discipline_facet Social Sciences
format Online Article
RSS Article
genre Journal Article
id rss_article:31565
institution FRELIP
journal_source_facet Health Economics Review
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review
— — — — — Economic Sciences General
Economics
Social Sciences
sub_discipline_display Economics
sub_discipline_facet Economics
subject_display — — — — — Economic Sciences General
Economics
Social Sciences
— — — — — Economic Sciences General
Economics
Social Sciences
subject_facet — — — — — Economic Sciences General
Economics
Social Sciences
title Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review
title_auth Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review
title_full Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review
title_fullStr Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review
title_full_unstemmed Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review
title_short Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review
title_sort consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature review
topic — — — — — Economic Sciences General
Economics
Social Sciences
url https://link.springer.com/article/10.1186/s13561-026-00771-7